Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain

NCT00640432 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: Diclofenac
DRUG: Celecoxib

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.